A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial (Q46862263)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 December 2007

Language	Label	Description	Also known as
English	A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial	scientific article published on 7 December 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

A COX-2 inhibitor combined with chemoradiation of locally advanced rectal cancer: a phase II trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

chemoradiotherapy

0 references

phase II clinical trial

0 references

Søren Rafaelsen

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

author name string

Anders Jakobsen

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

John Pløen Mortensen

2

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

Claus Bisgaard

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

Jan Lindebjerg

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

Vagn Ove Bendtsen

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

publication date

7 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

International Journal of Colorectal Disease

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

23

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

251-255

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

The importance of applicator design for intraluminal brachytherapy of rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy with preoperative radiotherapy in rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of celecoxib with percutaneous radiotherapy in patients with localised prostate cancer - a phase I study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Toxic epidermal necrolysis after celecoxib therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COX-2 inhibitors as radiosensitizing agents for cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18064474

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00384-007-0407-7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18064474

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46862263&oldid=2208187596"